Lv1
70 积分 2022-11-17 加入
How the bone microenvironment shapes the pre-metastatic niche and metastasis
3小时前
待确认
Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis
2个月前
已完结
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
6个月前
已完结
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
8个月前
已完结
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
8个月前
已完结
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC
9个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
1年前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
1年前
已完结
Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer
1年前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
1年前
已完结
皖公网安备34019202002308
